Cialis Sublingual
Cialis Sublingual Price range: $ 75,00 through $ 413,00
Back to products
Ciloxan Ophthalmic Solution
Ciloxan Ophthalmic Solution Price range: $ 50,00 through $ 63,00

Cialis Super Active

Price range: $ 45,00 through $ 470,00

Cialis Super Active is an advanced medication specifically formulated to provide effective treatment for erectile dysfunction. The soft gelatin capsule design ensures rapid absorption into the system, allowing the active ingredients to start working faster than traditional tablets. This potent formula offers a prolonged duration of action, providing reliable support for up to 36 hours. By enhancing blood flow to the pelvic region, it helps men achieve and maintain a firm erection during physical intimacy. It is a dependable choice for those looking to improve their sexual performance and restore confidence.

Active substance: Tadalafil
SKU: Cialis Super Active Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Cialis Super Active belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors, containing the active substance tadalafil. In the United States, tadalafil-based pharmacotherapies are prescription medicines dispensed in accordance with applicable federal and state regulations.

This formulation is utilized for the management of erectile dysfunction in adult males, operating through targeted vascular smooth muscle relaxation. A formal clinical evaluation by a licensed healthcare provider is required prior to initiating therapy to assess cardiovascular risk and rule out underlying conditions.

Parameter Specification
Active ingredient Tadalafil
Therapeutic class Phosphodiesterase type 5 (PDE5) inhibitor
Dosage form Oral soft gelatin capsule
Route of administration Oral
Primary purpose Management of erectile dysfunction
Prescription status Dispensed under applicable prescription regulations

Pharmacological Profile and Mechanism

Main uses

Cialis Super Active is indicated for the treatment of erectile dysfunction (ED) in adult males. Erectile dysfunction is characterized by the persistent inability to attain or maintain a penile erection sufficient for satisfactory sexual performance. Tadalafil, the active therapeutic moiety in this formulation, addresses the physiological mechanisms of vascular response within the corpus cavernosum. While the primary indication focuses on erectile dysfunction, tadalafil as a chemical compound is also studied and prescribed for signs and symptoms of benign prostatic hyperplasia (BPH) under specific FDA-approved dosing regimens. Use of this specific formulation for off-label purposes or unapproved secondary indications must be evaluated exclusively by a credentialed medical practitioner based on individual clinical profiles.

How the drug works

The mechanism of action of tadalafil involves the selective inhibition of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). During local sexual stimulation, nitric oxide (NO) is released from nerve terminals and endothelial cells in the corpus cavernosum. Nitric oxide stimulates the enzyme guanylate cyclase, leading to increased synthesis of cGMP. Elevated cGMP levels induce smooth muscle relaxation and enhanced arterial blood inflow into the erectile tissue. PDE5 is the primary enzyme responsible for the degradation of cGMP in the corpus cavernosum. By inhibiting PDE5, tadalafil preserves elevated cGMP concentrations, thereby enhancing the natural physiological erectile response to sexual stimulation without exerting a direct relaxant effect on isolated human corpus cavernosum in the absence of NO.

How it’s absorbed and eliminated

Following oral administration, tadalafil is absorbed rapidly, reaching peak plasma concentration within a median time of 2 hours post-dose. The rate and extent of systemic absorption are not significantly affected by food intake, allowing administration without regard to meals. Tadalafil exhibits extensive tissue distribution and is approximately 94% bound to plasma proteins, predominantly albumin and alpha-1-acid glycoprotein. Hepatic metabolism occurs primarily via the cytochrome P450 (CYP) 3A4 enzyme pathway, yielding a major circulating metabolite (methylcatechol glucuronide) that demonstrates negligible PDE5 inhibitory activity. The mean terminal elimination half-life of tadalafil in healthy subjects is approximately 17.5 hours, facilitating an extended therapeutic window. Excretion occurs predominantly as inactive metabolites, with approximately 61% recovered in feces and 36% in urine.

Dosing, Safety Profile, and Clinical Considerations

Dosing schedule: Dosing regimens for tadalafil must be individualized according to clinician recommendations and patient response. For on-demand administration prior to anticipated sexual activity, the starting dose is evaluated based on tolerability and clinical efficacy, taken at least 30 minutes before activity. Alternatively, once-daily dosing regimens utilize lower strengths taken at approximately the same time each day to maintain steady-state plasma concentrations. The maximum recommended dosing frequency for on-demand use is once per 24-hour period. Dosing adjustments may be necessary for patients with moderate renal impairment or mild-to-moderate hepatic impairment.

If you skip a dose: For individuals prescribed a once-daily regimen of tadalafil, a missed dose should be taken as soon as remembered on that day. However, if it is nearly time for the next scheduled dose, the missed dose should be omitted entirely, resuming the regular daily schedule. Patients must never double the dose or take extra medication to compensate for a missed administration, as excessive plasma concentrations increase the incidence and severity of adverse hemodynamic effects.

Compatibility with other medicines: Tadalafil demonstrates clinically significant drug interactions that require careful medical screening. Co-administration of tadalafil with any form of organic nitrates (such as nitroglycerin, isosorbide dinitrate, or isosorbide mononitrate) or nitric oxide donors (such as amyl nitrite) is strictly contraindicated due to potentiated hypotensive effects that can lead to life-threatening drops in blood pressure. Concomitant use with alpha-blockers (e.g., tamsulosin, doxazosin) or antihypertensive agents requires caution and dosage titration to avoid symptomatic orthostatic hypotension. Potent inhibitors of CYP3A4, such as ketoconazole, ritonavir, or erythromycin, significantly increase systemic exposure to tadalafil, necessitating lower doses. Conversely, CYP3A4 inducers like rifampin lower plasma concentrations, potentially reducing therapeutic efficacy.

What to avoid while taking it: Excessive alcohol consumption should be avoided when taking tadalafil. Concomitant ingestion of substantial amounts of alcohol (e.g., 5 units or more) alongside PDE5 inhibitors increases the risk of orthostatic signs and symptoms, including increased heart rate, decreased standing blood pressure, dizziness, and headache. Ingestion of grapefruit or grapefruit juice should also be limited or avoided, as bioactive compounds in grapefruit inhibit intestinal CYP3A4 enzymes, potentially increasing systemic tadalafil exposure and the risk of adverse reactions.

Adverse reactions: Clinical studies indicate that most adverse effects associated with tadalafil are transient and mild to moderate in severity. The most frequently reported adverse reactions include headache, dyspepsia (upset stomach), back pain, myalgia (muscle aches), nasal congestion, facial flushing, and limb pain. Back pain and myalgia generally occur 12 to 24 hours post-dose and typically resolve within 48 hours without intervention. Less common reactions include visual disturbances such as color vision changes or conjunctival hyperemia, and gastroesophageal reflux.

Red flags: Emergency medical attention must be sought immediately if patients experience signs of severe hypersensitivity, such as swelling of the face, lips, tongue, or throat, or severe dyspnea. Sudden decrease or loss of hearing, sometimes accompanied by tinnitus and dizziness, requires immediate discontinuation of the medication and medical evaluation. Patients experiencing sudden monocular visual impairment should seek prompt medical assistance, as this may indicate non-arteritic anterior ischemic optic neuropathy (NAION). Additionally, any erection that persists longer than 4 hours (priapism) requires emergency urological intervention to prevent irreversible penile tissue damage.

Important precautions: Evaluation of cardiovascular status is an essential prerequisite before starting tadalafil, as sexual activity carries an inherent cardiac risk for patients with pre-existing cardiovascular disease. Tadalafil is not recommended for patients with unstable angina, recent myocardial infarction (within the past 90 days), recent stroke (within the past 6 months), uncontrolled arrhythmias, severe hypotension (<90/50 mmHg), or uncontrolled hypertension. Caution is warranted in patients with anatomical deformation of the penis (e.g., Peyronie’s disease) or conditions predisposing to priapism (e.g., sickle cell anemia, multiple myeloma, leukemia). Safety and efficacy have not been established in pediatric populations under 18 years of age. Tadalafil is not indicated for use in female patients.

Common questions

How does food consumption affect the performance of this medication?
Clinical pharmacokinetic studies demonstrate that food intake does not alter the rate or extent of absorption of tadalafil to a clinically meaningful degree. Consequently, the medication may be taken independently of meals. High-fat meals do not delay the time to peak plasma concentration, unlike some other agents within the PDE5 inhibitor class.

Is it safe to drive or operate machinery after taking tadalafil?
While tadalafil has no direct effect on psychomotor performance, clinical trial data note that dizziness and transient visual changes can occur in some individuals. Patients should observe their individual response to the medication prior to driving, operating heavy machinery, or engaging in tasks requiring sharp visual acuity or concentration.

What should be done if a patient experiences muscle pain after dosing?
Myalgia and back pain are known adverse effects associated with PDE5 inhibition, typically appearing 12 to 24 hours after administration. These symptoms are generally mild to moderate and self-limiting. If discomfort persists or interferes with daily function, a physician should be consulted to discuss symptom management or dose adjustment.

Can tadalafil be taken at the same time as blood pressure medications?
Tadalafil exhibits minor vasodilatory properties that can complement or interact additively with antihypertensive agents. Patients taking blood pressure lowering medications must be monitored by their prescriber to prevent additive hypotensive effects, particularly when starting treatment or adjusting doses.

What is the protocol if an unexpected adverse effect occurs?
In the event of unexpected or severe adverse effects, administration should be halted, and a healthcare provider should be notified promptly. Suspected adverse events may also be reported directly to the FDA MedWatch program to assist in ongoing safety surveillance.

In accordance with FDA requirements. This text is for informational purposes only and does not constitute individual medical advice. Always consult a qualified healthcare professional regarding clinical decisions and prescription guidance.

Additional information
Dosage

20mg

,

40 mg

Package

10 caps

,

20 caps

,

30 caps

,

30 tabs

,

60 caps

,

60 tabs

,

90 caps

,

90 tabs

,

120 caps

,

120 tabs

,

180 caps

,

180 tabs

,

270 caps

,

360 caps

,

360 tabs

Ενεργός Ουσία